September quarter revenue and profit fall sharply; new defence and pharma objects proposed
EIMCOELECO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 12.9 pts less than Nifty Microcap 250 and 12.3 pts less than its Industrial Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
For the September 2025 quarter, revenue from operations was Rs 3,323.64 lakh versus Rs 6,662.69 lakh a year ago, and net profit was Rs 535.12 lakh versus Rs 1,306.15 lakh. EPS was Rs 9.28. For the half year, revenue was Rs 10,080.63 lakh and profit Rs 1,983.38 lakh. The auditor review was unmodified. The board also proposed wider business objects.
Weaker sales and profit are likely to weigh on the stock, but proposed defence and pharma business lines offer long-term growth options.